We are live on ! Find out more
GSC

G&S Capital Portfolio holdings

AUM $345M
1-Year Est. Return 32.53%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
+32.53%
3 Year Est. Return
+77.18%
5 Year Est. Return
+99.48%
10 Year Est. Return
AUM
$285M
AUM Growth
+$1.52M
Cap. Flow
-$2.37M
Cap. Flow %
-0.83%
Top 10 Hldgs %
30.64%
Holding
143
New
11
Increased
68
Reduced
47
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 10.26%
2 Financials 7.53%
3 Industrials 6.32%
4 Healthcare 5.11%
5 Consumer Staples 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$17.3M 6.07%
26,552
+754
+3% +$513K
VTV icon
2
Vanguard Value ETF
VTV
$186B
$12M 4.2%
60,972
+725
+1% +$145K
SPTM icon
3
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$11.1M 3.89%
140,037
-12,515
-8% -$1.03M
BIL icon
4
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
$10.2M 3.59%
111,461
+18,551
+20% +$1.7M
QQQ icon
5
Invesco QQQ Trust
QQQ
$466B
$8.43M 2.96%
14,614
+306
+2% +$186K
MDY icon
6
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$6.53M 2.29%
10,588
+201
+2% +$127K
IJR icon
7
iShares Core S&P Small-Cap ETF
IJR
$110B
$6.42M 2.25%
51,605
+1,542
+3% +$196K
CVX icon
8
Chevron
CVX
$373B
$5.79M 2.03%
27,972
-1,373
-5% -$250K
AAPL icon
9
Apple
AAPL
$4.9T
$5.03M 1.77%
19,828
+54
+0.3% +$14.1K
NVDA icon
10
NVIDIA
NVDA
$4.91T
$4.48M 1.57%
25,667
-4,773
-16% -$876K
SPLV icon
11
Invesco S&P 500 Low Volatility ETF
SPLV
$7.19B
$4.48M 1.57%
61,199
+4,269
+7% +$316K
PG icon
12
Procter & Gamble
PG
$349B
$4.46M 1.57%
30,883
+1,116
+4% +$169K
FEOE
13
First Eagle Overseas Equity ETF
FEOE
$1.5B
$4.27M 1.5%
84,699
+23,773
+39% +$1.23M
CGUS icon
14
Capital Group Core Equity ETF
CGUS
$11.2B
$4.19M 1.47%
108,972
+4,361
+4% +$176K
DOW icon
15
Dow Inc
DOW
$21.6B
$4.15M 1.46%
99,626
+72,377
+266% +$2.3M
SPDW icon
16
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.6B
$4.09M 1.44%
89,680
+10,895
+14% +$511K
RDVI icon
17
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
$3.48B
$4.04M 1.42%
158,181
+11,479
+8% +$307K
ABBV icon
18
AbbVie
ABBV
$450B
$3.97M 1.39%
18,242
+554
+3% +$123K
SDVD icon
19
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
$921M
$3.9M 1.37%
179,779
+12,302
+7% +$276K
CGXU icon
20
Capital Group International Focus Equity ETF
CGXU
$6.07B
$3.88M 1.36%
131,499
+2,387
+2% +$73.6K
AMLP icon
21
Alerian MLP ETF
AMLP
$12.7B
$3.81M 1.34%
72,468
+388
+0.5% +$19.8K
DELL icon
22
Dell
DELL
$256B
$3.78M 1.33%
23,037
+12,317
+115% +$1.64M
SPMD icon
23
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.1B
$3.77M 1.33%
63,742
-13,783
-18% -$839K
JIVE icon
24
JPMorgan International Value ETF
JIVE
$3.22B
$3.77M 1.33%
44,066
+18,358
+71% +$1.58M
GSST icon
25
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.54B
$3.76M 1.32%
74,326
+13,630
+22% +$689K

Similar funds

G&S Capital's Q1 2026 Portfolio in Review

As of Q1 2026, G&S Capital held 143 positions worth $285M, up 0.54% from $283M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

G&S Capital's Q1 2026 filing shows 11 new, 68 increased, 47 reduced and 10 closed positions. Its largest new stake was Medtronic: 28,913 shares worth $2.51M. The largest sale was Invesco S&P SmallCap Health Care ETF, an estimated $3.26M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

  • G&S Capital's largest Q1 2026 buy was Medtronic: 28,913 shares worth $2.51M.
  • G&S Capital added most to Dow Inc in Q1 2026, an estimated $2.3M increase.
  • G&S Capital's biggest Q1 2026 reduction was UnitedHealth, cutting an estimated $2.6M.
  • G&S Capital fully exited Invesco S&P SmallCap Health Care ETF in Q1 2026, selling an estimated $3.26M.
  • G&S Capital's ten largest holdings make up 31% of its $285M portfolio in Q1 2026.
  • G&S Capital opened 11 new positions and closed 10 in Q1 2026.
  • G&S Capital's portfolio value rose 0.54% quarter-over-quarter to $285M.

Based on G&S Capital's 13F filing for Q1 2026, filed 7 Apr 2026.